Infectious Disease Book



Aka: Menomune, MPSV4, Quadrivalent Meningococcal Polysaccharide Vaccine
  1. See Also
    1. Meningococcal Vaccine (Menactra, Menveo, MCV4)
    2. Serotype B Meningococcal Vaccine ( Trumenba, Bexero)
    3. Neisseria Meningitidis
    4. Bacterial Meningitis
  2. Indications
    1. See Menactra (MCV4) which is preferred due to higher immunogenicity
  3. Mechanism
    1. Quadrivalent Meningococcal Polysaccharide Vaccine
    2. Covers strains A, C, W-135, and Y (does not contain B serotype)
      1. Covers same strains as Menactra
      2. See Menactra for further explanation
    3. Cost: $100 (similar to Menactra)
    4. Storage: 35 to 46 F (2 to 8 C), Same as Menactra
  4. Dose: Menomune
    1. Adult: 0.5 ml SC every 3 years
    2. Intramuscular may be preferred over subcutaneous route
      1. Intramuscular Injection reduces adverse effects
        1. Local erythema (11% for IM, 32% for SC)
        2. Headache (3% for IM and 12% for SC)
      2. Intramuscular has same efficacy as subcutaneous route
  5. Efficacy
    1. Like Menactra, Menomune has a high seroconversion rate (98%-100%)
    2. However Menomune duration is much shorter
      1. Menomune duration lasts 3 years in school age children and less in infants
  6. Precautions: Safety
    1. No longer contains Thimerosal
    2. Approved for all ages
    3. Safe in Human Immunodeficiency Virus (HIV)
      1. See Immunization in HIV
  7. Adverse effects
    1. Serious adverse events are uncommon (<1.3%)
    2. Headache
    3. Fever (in up to 3% of children)
    4. Local reactions (more common with Menactra)
  8. References
    1. Bilukha (2005) MMWR Recomm Rep 54(RR-7):1-21 [PubMed]
    2. Peter (2001) Pediatr Infect Dis J 20:311-2 [PubMed]
    3. Ruben (2001) Clin Infect Dis 32:170-2 [PubMed]

Menomune (C0244512)

Concepts Pharmacologic Substance (T121) , Immunologic Factor (T129)
MSH D022401
French Menomune
English menomune, Sanofi Pasteur Brand of Meningococcal Polysaccharide Vaccine, Menomune
Derived from the NIH UMLS (Unified Medical Language System)

You are currently viewing the original '\legacy' version of this website. Internet Explorer 8.0 and older will automatically be redirected to this legacy version.

If you are using a modern web browser, you may instead navigate to the newer desktop version of fpnotebook. Another, mobile version is also available which should function on both newer and older web browsers.

Please Contact Me as you run across problems with any of these versions on the website.

Navigation Tree